• Subject: Re: IBM Spin Doctors on AS/400 Marketing
  • From: John Carr <74711.77@xxxxxxxxxxxxxx>
  • Date: Fri, 31 Oct 1997 16:52:27 -0500

Chris  Rehms  said:

>Okay. What are you talking about? Is there an NT ad that has happy faces
on it? Have you ever
> seen a television NT ad? I'm serious, maybe I just don't watch the right
shows, but I haven't ever seen >one. Give me a little feedback on what they
are like. <

Chris,  Chris , Chris;

It doesn't matter if there ACTUALLY are ads saying NT does this or that. 

If I said,     "Cary Grant"    you'd probably think      "Judy, Judy, Judy'
Even though he never ACTUALLY said it.

If I said   "Carl Sagan"   You'd probably think      "Billions and
Even though he never ACTUALLY said it. 

NT (Right now)  Doesn't ACTUALLY work better than Novell.
but if you poll 100  IS people,  I'd bet the majority would say it does.

That is the point.

Perception is reality.     I'd also bet in 6 mos.   If I said Lotus Notes
(an application right?)
the majority of people would think  "You need a NT to run it the best."    
Sadly because    "NT is Soooo scaleable"!

Perception babe.

BTW ,     NT isn't an app is it?        No?     Then it should be as
obscure as the AS/400 is right?
Could it be that MARKETING and Brandname (AS/400 not IBM) recognition is
the difference?

As Firesign Theater used to say   "Those are the headlines,  now for the
rumors behind the news"

John Carr
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to "MIDRANGE-L@midrange.com".
| To unsubscribe from this list send email to MAJORDOMO@midrange.com
|    and specify 'unsubscribe MIDRANGE-L' in the body of your message.
| Questions should be directed to the list owner/operator: david@midrange.com

This thread ...

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2020 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].